Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Influenza and Other Respiratory Viruses
|
April 8, 2014
Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines
Gerrit A van Essen, Jiri Beran, Jeanne-Marie Devaster, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 29, 2026
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420
May S ElSherif, Kara L Redden, Joanne M Langley, et al.
The Journal of Infectious Diseases
|
June 8, 2017
Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial
Li-Min Huang, Thanyawee Puthanakit, Chiu Cheng-Hsun, et al.
Human Vaccines & Immunotherapeutics
|
October 4, 2016
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis
Guillermo M Ruiz-Palacios, Geert Leroux-Roels, Jiri Beran, et al.
The Journal of Infectious Diseases
|
July 13, 2013
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children
Joanne M Langley, Alfonso Carmona Martinez, Archana Chatterjee, et al.
International Journal of Cancer
|
December 22, 2015
Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study
S Rachel Skinner, Cosette M Wheeler, Barbara Romanowski, et al.
The Lancet. Infectious Diseases
|
March 23, 2013
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial
Janet E McElhaney, Jiri Beran, Jeanne-Marie Devaster, et al.
The Lancet. Infectious Diseases
|
July 5, 2016
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
Cosette M Wheeler, S Rachel Skinner, M Rowena Del Rosario-Raymundo, et al.
Influenza and Other Respiratory Viruses
|
March 13, 2025
The Global Influenza Hospital Surveillance Network: A Multicountry Public Health Collaboration
Marta C Nunes, Cecile Chauvel, Sonia M Raboni, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Influenza and Other Respiratory Viruses
|
April 8, 2014
Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines
Gerrit A van Essen, Jiri Beran, Jeanne-Marie Devaster, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 29, 2026
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420
May S ElSherif, Kara L Redden, Joanne M Langley, et al.
The Journal of Infectious Diseases
|
June 8, 2017
Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial
Li-Min Huang, Thanyawee Puthanakit, Chiu Cheng-Hsun, et al.
Human Vaccines & Immunotherapeutics
|
October 4, 2016
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis
Guillermo M Ruiz-Palacios, Geert Leroux-Roels, Jiri Beran, et al.
The Journal of Infectious Diseases
|
July 13, 2013
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children
Joanne M Langley, Alfonso Carmona Martinez, Archana Chatterjee, et al.
International Journal of Cancer
|
December 22, 2015
Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study
S Rachel Skinner, Cosette M Wheeler, Barbara Romanowski, et al.
The Lancet. Infectious Diseases
|
March 23, 2013
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial
Janet E McElhaney, Jiri Beran, Jeanne-Marie Devaster, et al.
The Lancet. Infectious Diseases
|
July 5, 2016
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
Cosette M Wheeler, S Rachel Skinner, M Rowena Del Rosario-Raymundo, et al.
Influenza and Other Respiratory Viruses
|
March 13, 2025
The Global Influenza Hospital Surveillance Network: A Multicountry Public Health Collaboration
Marta C Nunes, Cecile Chauvel, Sonia M Raboni, et al.
Page
of 7